Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). Microviable Team joins [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and Pilar Manrique, PhD, Research Scientist, will be attending the 8th Microbiome Movement - Drug Development Summit Europe which will take place from 30 January to 1 February 2024 [...]
Microviable Therapeutics will participate in Microbiome Connect USA that will take place from November 14th to 16th in Boston. Claudio Hidalgo Cantabrana, CEO at Microviable, will join a like-minded community of 300 scientists and entrepreneurs [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending HLTH 2023 event in Las Vegas (USA) from October 8th to 11th. HLTH 2023 is the preeminent event [...]
Claudio Hidalgo Cantabrana, PhD, CEO at Microviable, and our CBO, Rafael M. Permuy, MBA, will be attending BIO-Europe event in Leipzig, Germany, from October 24th to 26th. BIO-Europe® is the preeminent partnering conference for the [...]
Microviable Therapeutics will be presenting at I Asturias International Meeting on Clinical Microbiology and Infectious Disease (AIMID 2022) on September 22-23. Claudio Hidalgo, CEO at Microviable, will discuss the use of “Microbiome-derived biotherapeutic products for [...]